Gedeon Richter

Richter aspires to be a global innovator in some key scientific fields, while dedicated to making medicines more accessible worldwide.

Founded in 1901, headquartered in Hungary, with a market capitalization of EUR 4.7bn and sales of EUR 2.2bn in 2024, it operates Central Europe's largest R&D hub.

Its research drives breakthroughs in Neuropsychiatry and Women's Healthcare, while Biotechnology and General Medicines strengthen its affordable treatment portfolio.

Committed to sustainable growth, Richter invests in R&D, manufacturing excellence, and digitalization to advance medical innovation.